WXXWY WUXI BIOLGCS ADRWatchlist
About WUXI BIOLGCS ADR Company
Wuxi Biologics (Cayman), Inc. is an investment holding company, which engages in the discovery, development and manufacture of biologics services. Its services include testing; clinical drug substance cGMP manufacture; commercial drug substance cGMP manufacture; drug product cGMP fill and finish; antibody drug conjugates; regulatory affairs; and technologies and platforms. The company was founded on May 24, 2010 and is headquartered in Wuxi, China.
Nanbei Water | Nanshui's net sales of A-shares exceeded 7.5 billion dollars throughout the day, sold Wuliangye and Maotai, and Beishui rushed to raise the Prosperity Fund
Track the latest developments in north-south funding
Nomura Adjusts Wuxi Biologics' Price Target to HK$58.44 From HK$82.69, Keeps at Buy
06:14 AM EST, 12/05/2023 (MT Newswires) -- Nomura Adjusts Wuxi Biologics' Price Target to HK$58.44 From HK$82.69, Keeps at Buy Price (HKD): $30.35, Change: $-2.80, Percent Change: -8.45%
The CXO leader continues to collapse! Yaoming Biotech got on the “jumping plane” and plummeted by more than 30% in two days. What do the institutions think?
The decline is unstoppable.
Chinese pharma $WUXI BIO(02269.HK)$ sagged 5% to $31.5 after resumption of trading in the morning session. $WUXI APPTEC(02359.HK)$ lost 3.4%.
For financials, $HSBC HOLDINGS(00005.HK)$ climbed 0.2% to $59.8, whi...